US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.42

+0.130010.08%

Post-market: 1.430.0100+0.70%19:25 EDT

Volume:3.48M

Turnover:4.93M

Market Cap:310.60M

PE:-1.16

High:1.47

Open:1.30

Low:1.29

Close:1.29

Loading ...

Overview Company News Filings

Allogene Therapeutics Up Nearly 42%, on Pace for Record Percent Increase -- Data Talk

William Blair Sticks to Its Buy Rating for Allogene Therapeutics (ALLO)

BRIEF-Allogene Therapeutics Announces Publication Of Durable Response Data From Phase 1 Alpha/Alpha2 Trials Of The Allogeneic Car T Cemacabtagene Ansegedleucel/Allo-501

Allogene publishes data from ALPHA, ALPHA2 trials of cemacabtagene ansegedleucel

Allogene Therapeutics Announces Publication of Durable Response Data From Phase 1 Alpha/Alpha2 Trials of the Allogeneic Car T Cemacabtagene Ansegedleucel/Allo-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology

THOMSON REUTERS

Allogene Therapeutics Inc - Cema-Cel Achieves Orr of 58% and Cr of 42% in Study

THOMSON REUTERS

Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology

Allogene Therapeutics Announces Participation in February Investor Conferences

FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases

Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer

THOMSON REUTERS

Press Release: Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer

Canaccord Genuity Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)

Allogene Therapeutics Cleared to Start Phase 1 Testing of ALLO-329 Drug Candidate

MT Newswires Live

Allogene announces FDA cleared IND application for study of ALLO-329

Allogene Therapeutics Inc - Resolution Trial to Begin Mid-2025

THOMSON REUTERS

Allogene Therapeutics Secures U.S. FDA Ind Clearance for Allo-329, Advancing Its Next-Generation Allogeneic Car T Into Autoimmune Diseases

THOMSON REUTERS

Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases

Press Release: Vor Bio Announces $55.6 Million Private Placement

3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025

Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock?

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ALLO/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLO\",,,,,undefined,":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":1.42,"timestamp":1749240000000,"preClose":1.29,"halted":0,"volume":3475881,"hourTrading":{"tag":"盘后","latestPrice":1.43,"preClose":1.42,"latestTime":"19:25 EDT","volume":12841,"amount":18290.8329,"timestamp":1749252306667},"delay":0,"floatShares":156516198,"shares":218730809,"eps":-1.222676,"marketStatus":"Market Closed","change":0.13,"latestTime":"06-06 16:00:00 EDT","open":1.3,"high":1.47,"low":1.29,"amount":4930082.9008533,"amplitude":0.139535,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.222676,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1539230400000,"exchange":"NASDAQ","adjPreClose":1.29,"preHourTrading":{"tag":"盘前","latestPrice":1.31,"preClose":1.29,"latestTime":"09:13 EDT","volume":32491,"amount":42241.6953095,"timestamp":1749215598422},"postHourTrading":{"tag":"盘后","latestPrice":1.43,"preClose":1.42,"latestTime":"19:25 EDT","volume":12841,"amount":18290.8329,"timestamp":1749252306667},"volumeRatio":1.1608218044410228,"impliedVol":0.9938,"impliedVolPercentile":0.676},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLO\",,,,,undefined,":{"symbol":"ALLO","floatShares":156516198,"roa":"-28.92%","roe":"-59.60%","lyrEps":-1.32225,"volumeRatio":1.1608218044410228,"shares":218730809,"dividePrice":0,"high":1.47,"amplitude":0.139535,"preClose":1.29,"low":1.29,"week52Low":0.8621,"pbRate":"0.81","week52High":3.78,"institutionHeld":0,"latestPrice":1.42,"eps":-1.222676,"divideRate":0,"volume":3475881,"delay":0,"ttmEps":-1.222676,"open":1.3,"prevYearClose":2.13,"prevWeekClose":1.17,"prevMonthClose":1.17,"prevQuarterClose":1.46,"fiveDayClose":1.17,"twentyDayClose":1.18,"sixtyDayClose":2.06},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALLO\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2511661837","title":"Allogene Therapeutics Up Nearly 42%, on Pace for Record Percent Increase -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661837","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511661837?lang=en_us&edition=fundamental","pubTime":"2025-02-15 01:06","pubTimestamp":1739552760,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics, Inc.  is currently at $2.00, up $0.59 or 41.84%. --Would be highest close since Jan. 10, 2025, when it closed at $2.06. --Down 96.3% from its all-time closing high of $54.04 on May 22, 2020. --Down 58.25% from 52 weeks ago , when it closed at $4.79. --Up 42.85% from its 52-week closing low of $1.40 on Feb. 11, 2025. --Traded as high as $2.02; highest intraday level since Jan. 28, 2025, when it hit $2.11. --Up 42.91% at today's intraday high; largest intraday percent increase on record ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LENZ","BK4139","ALLO"],"gpt_icon":0},{"id":"2511524936","title":"William Blair Sticks to Its Buy Rating for Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2511524936","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511524936?lang=en_us&edition=fundamental","pubTime":"2025-02-14 17:15","pubTimestamp":1739524532,"startTime":"0","endTime":"0","summary":"In a report released today, Sami Corwin from William Blair maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report). The company’s...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-its-buy-rating-for-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-sticks-to-its-buy-rating-for-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO"],"gpt_icon":0},{"id":"2511848505","title":"BRIEF-Allogene Therapeutics Announces Publication Of Durable Response Data From Phase 1 Alpha/Alpha2 Trials Of The Allogeneic Car T Cemacabtagene Ansegedleucel/Allo-501","url":"https://stock-news.laohu8.com/highlight/detail?id=2511848505","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511848505?lang=en_us&edition=fundamental","pubTime":"2025-02-14 06:15","pubTimestamp":1739484940,"startTime":"0","endTime":"0","summary":"BRIEF-Allogene Therapeutics Announces Publication Of Durable Response Data From Phase 1 Alpha/Alpha2 Trials Of The Allogeneic Car T Cemacabtagene Ansegedleucel/Allo-501Feb 13 (Reuters) - Allogene Ther","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUA7ZBDSB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","ALLO","BK4139"],"gpt_icon":1},{"id":"2511508193","title":"Allogene publishes data from ALPHA, ALPHA2 trials of cemacabtagene ansegedleucel","url":"https://stock-news.laohu8.com/highlight/detail?id=2511508193","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511508193?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:45","pubTimestamp":1739483145,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ansegedleucel in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allogene-publishes-data-from-alpha-alpha2-trials-of-cemacabtagene-ansegedleucel?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allogene-publishes-data-from-alpha-alpha2-trials-of-cemacabtagene-ansegedleucel?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2511957073","title":"Allogene Therapeutics Announces Publication of Durable Response Data From Phase 1 Alpha/Alpha2 Trials of the Allogeneic Car T Cemacabtagene Ansegedleucel/Allo-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2511957073","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511957073?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:30","pubTimestamp":1739482230,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUA7ZBDSB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALLO","BK4505"],"gpt_icon":0},{"id":"2511570223","title":"Allogene Therapeutics Inc - Cema-Cel Achieves Orr of 58% and Cr of 42% in Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2511570223","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511570223?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:30","pubTimestamp":1739482230,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250213:nTUA7ZBDSB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2511085575","title":"Allogene Therapeutics Announces Publication of Durable Response Data from Phase 1 ALPHA/ALPHA2 Trials of the Allogeneic CAR T Cemacabtagene Ansegedleucel/ALLO-501 in Relapsed/Refractory Large B-Cell Lymphoma in the Journal of Clinical Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=2511085575","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511085575?lang=en_us&edition=fundamental","pubTime":"2025-02-14 05:30","pubTimestamp":1739482200,"startTime":"0","endTime":"0","summary":"Efficacy Comparable to Approved Autologous CD19 CAR Ts:Achieved Overall Response  and Complete Response  Rates of 58% and 42% Across the Study and 67% and 58% with Pivotal Study Regimen, Respectively. Durability of Response:Among Patients Who Achieved CR, Median Duration of Response  of 23.1 Months and Median Overall Survival  Not Reached. Foundation for Cema-Cel in ALPHA3 Trial in First Line  Consolidation: Achieved 100% CR in Patients with Low Disease Burden. \"With multiple patients in ongoing complete remissions beyond four years, the lingering question of whether an allogeneic CAR T could deliver durable responses has now been answered,\" said Zachary Roberts, M.D., Ph.D., Executive Vice President, Research and Development and Chief Medical Officer of Allogene. \"Furthermore, these results provide potent evidence supporting the use of CAR T in patients with low disease burden and the unique opportunity for the ALPHA3 trial to achieve something novel in this disease – predict and inte","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-announces-publication-durable-213000140.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4097","BK4161","BK4022","CR","BK4230","LU2065731478.USD","CAR","IE00B7SZL793.SGD","ALLO","BK4213","BK4505","SOC","IE0031619046.USD","BK4139","ORR","OS","IE00B66KJ199.SGD","BK4006","CRS","IE00B19Z4B17.USD"],"gpt_icon":0},{"id":"2508518624","title":"Allogene Therapeutics Announces Participation in February Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2508518624","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508518624?lang=en_us&edition=fundamental","pubTime":"2025-02-04 21:30","pubTimestamp":1738675800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Feb. 04, 2025  -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T  products for cancer and autoimmune disease, today announced that it will participate in one upcoming investor conference in February.Any available webcasts will be posted to the Company's website atwww.allogene.com under the Investors tab in the News and Events section. Following a live webcast, a replay will be available on the Company's website for approximately 30 days.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-announces-participation-february-133000758.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2507487654","title":"FDA Clears Allogene's IND for CAR T Therapy in Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2507487654","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507487654?lang=en_us&edition=fundamental","pubTime":"2025-01-30 00:34","pubTimestamp":1738168440,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics, Inc. ALLO announced that the FDA has cleared its investigational new drug  application to begin clinical studies on its investigational CRISPR-based allogenic CAR-T therapy, ALLO-329, for the treatment of various autoimmune diseases.The phase I RESOLUTION basket study will evaluate the safety and preliminary efficacy of ALLO-329 in patients with systemic lupus erythematosus, including lupus nephritis, idiopathic inflammatory myopathies and systemic sclerosis.The study, which aims to offer a key understanding of ALLO-329's potential to transform the treatment paradigm across a range of autoimmune diseases, is expected to begin in mid-2025. The company expects to have proof-of-concept from the basket study by the end of 2025.A next-generation allogeneic CAR T-cell therapy, ALLO-329, works by targeting both CD19+ B-cells and CD70+ activated T-cells. Additionally, the candidate incorporates ALLO’s proprietary Dagger technology, which is designed to reduce or eliminat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/fda-clears-allogenes-ind-car-163400440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CSTL","BMRN","CAR","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4196","IE00B19Z3B42.SGD","IE0002270589.USD","BK4566","BK4139","BK4007","BK4505","ALLO","HRMY"],"gpt_icon":0},{"id":"2507633032","title":"Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2507633032","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507633032?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:30","pubTimestamp":1738157402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUA2RRG5W:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2507330686","title":"Press Release: Allogene Therapeutics Announces Benjamin M. Beneski as Senior Vice President and Chief Technical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2507330686","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507330686?lang=en_us&edition=fundamental","pubTime":"2025-01-29 21:30","pubTimestamp":1738157400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Jan. 29, 2025  -- Allogene Therapeutics, Inc. , a clinical-stage biotechnology company pioneering the development of allogeneic CAR T  products for cancer and autoimmune disease, today announced that Benjamin M. Beneski has been promoted to Senior Vice President and Chief Technical Officer . Mr. Beneski succeeds Tim Moore, who will be stepping down at the end of February after two years with the Company. Mr. Moore's impactful career spans nearly a decade of collaboration with the broader team, during which he made significant contributions to Allogene and the field of cell and gene therapy.As CTO, Mr. Beneski will oversee Allogene's technical operations, leveraging his extensive expertise in biologics manufacturing, process development, and operational leadership to carry on the work of Mr. Moore and further advance the company's groundbreaking allogeneic cell therapy programs.Mr. Beneski's career spans over two decades in biologics manufacturing and techni","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTO","BK4139","03160","ALLO","BK4555","BK4588","LENZ","BK4585","BK4505","TM","BK4099","BK4160"],"gpt_icon":0},{"id":"2507721687","title":"Canaccord Genuity Reaffirms Their Buy Rating on Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2507721687","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507721687?lang=en_us&edition=fundamental","pubTime":"2025-01-29 20:26","pubTimestamp":1738153584,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst John Newman maintained a Buy rating on Allogene Therapeutics (ALLO – Research Report) today and set a price target of $14...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-reaffirms-their-buy-rating-on-allogene-therapeutics-allo?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO"],"gpt_icon":0},{"id":"2506510250","title":"Allogene Therapeutics Cleared to Start Phase 1 Testing of ALLO-329 Drug Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2506510250","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506510250?lang=en_us&edition=fundamental","pubTime":"2025-01-28 23:54","pubTimestamp":1738079669,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics  has been cleared by US regulators to begin phase 1 testing of its ALLO-329 drug candidate in patients with systemic lupus erythematosus.The upcoming study approved by the US Food and Drug Administration and slated to begin by mid-2025 takes in several types of rheumatological disorders and will evaluate the safety and efficacy of ALLO-329 in patients with lupus nephritis, idiopathic inflammatory myopathies and systemic sclerosis.The trial design also is intended to increase CAR-T cell expansion in patients and prevent rejection by having two distinct lymphodepletion arms, with patients in one part of the study receiving a dose of cyclophosphamide alone which is used by rheumatologists and the other that eliminates lymphodepletion entirely, the company said.Allogene shares were 0.3% lower in recent trading.Price: 1.95, Change: +0.02, Percent Change: +0.78","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2506851529","title":"Allogene announces FDA cleared IND application for study of ALLO-329","url":"https://stock-news.laohu8.com/highlight/detail?id=2506851529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506851529?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:35","pubTimestamp":1738071332,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) announced that the U.S. Food and Drug Administration, FDA, has cleared its Investigational New Drug, IND, application ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/allogene-announces-fda-cleared-ind-application-for-study-of-allo-329?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/allogene-announces-fda-cleared-ind-application-for-study-of-allo-329?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2506515684","title":"Allogene Therapeutics Inc - Resolution Trial to Begin Mid-2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2506515684","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506515684?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:30","pubTimestamp":1738071002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nTUA8HWGVZ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2506155955","title":"Allogene Therapeutics Secures U.S. FDA Ind Clearance for Allo-329, Advancing Its Next-Generation Allogeneic Car T Into Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2506155955","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506155955?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:30","pubTimestamp":1738071002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250128:nTUA8HWGVZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2506851576","title":"Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2506851576","media":"GlobeNewswire","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506851576?lang=en_us&edition=fundamental","pubTime":"2025-01-28 21:30","pubTimestamp":1738071000,"startTime":"0","endTime":"0","summary":"Dual-Targeted CD19/CD70 Allogeneic CAR T: Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease Indications. Innovative Dagger Technology: Empowers ALLO-329 to Overcome Rejection, Potentially Reducing or Eliminating Reliance on Traditional Lymphodepletion. Phase 1 RESOLUTION Rheumatology Basket Trial: Initiation Planned for Mid-2025, Targeting Proof-of-Concept to Demonstrate Allogeneic Potential and the Dagger Effect on Lymphodepletion by Year-End 2025. ALLO-329 represents a next-generation approach to autoimmune therapy, featuring a dual-targeting design against CD19+ B-cells and CD70+ activated T-cells. This innovative strategy is designed to deliver superior therapeutic benefit by addressing both B-cell and T-cell dysfunction, which drive immune dysregulation in autoimmune diseases. The incorporation of Allogene’s proprieta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-secures-u-fda-133000401.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALLO","BK4139","CAR","BK4230","BK4022","BK4505"],"gpt_icon":0},{"id":"2494538336","title":"Press Release: Vor Bio Announces $55.6 Million Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2494538336","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494538336?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:00","pubTimestamp":1735308000,"startTime":"0","endTime":"0","summary":"Intend to announce updated clinical data from Phase 1/2 VBP301 trial of VCAR33 in the first half of 2025 and updated clinical data from Phase 1/2a VBP101 trial of trem-cel in combination with Mylotarg in the second half of 2025. Extends cash runway through release of updated data from VBP101 and VBP301 trials in 2025. Vor Bio expects to use net proceeds from the PIPE to fund clinical and preclinical development of its pipeline candidates and for general corporate purposes. The PIPE is expected to close on December 30, 2024, subject to the satisfaction of customary closing conditions.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4505","VOR","ALLO"],"gpt_icon":0},{"id":"2494489498","title":"3 Beaten-Down Biotech Stocks to Buy for a Turnaround in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2494489498","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494489498?lang=en_us&edition=fundamental","pubTime":"2024-12-27 02:07","pubTimestamp":1735236420,"startTime":"0","endTime":"0","summary":"The biotech sector witnessed a see-saw performance in 2024. Though the year started on a positive note, those gains were erased in the second half due to disappointing third-quarter results, guidance cuts, pipeline setbacks and the appointment of vaccine skeptic Robert F. Kennedy Jr. as the head of Health and Human Services.Despite these setbacks, the sector continued to attract investors’ attention due to demand for innovative medicines, especially in areas with great commercial potential, like obesity, immunology and gene therapy. New drug approvals, pipeline progress and an increase in M&A activity were some of the positives in the sector in 2024.Here, we discuss three drug/biotech stocks that took a beating in 2024 but are likely to bounce back in 2025 based on anticipated regulatory approvals and/or positive pipeline updates. These are Immunocore Holdings IMCR, Allogene Therapeutics ALLO and Day One Biopharmaceuticals DAWN.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/3-beaten-down-biotech-stocks-180700940.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALLO","IMCR","BK4080","BK4231","DAWN","BK4505","BK4539","ADC","BK4139"],"gpt_icon":0},{"id":"2494889959","title":"Allogene Therapeutics (ALLO) Upgraded to Buy: What Does It Mean for the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2494889959","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494889959?lang=en_us&edition=fundamental","pubTime":"2024-12-27 01:00","pubTimestamp":1735232410,"startTime":"0","endTime":"0","summary":"Investors might want to bet on Allogene Therapeutics , as it has been recently upgraded to a Zacks Rank #2 . This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.The Zacks rating relies solely on a company's changing earnings picture. It tracks EPS estimates for the current and following years from the sell-side analysts covering the stock through a consensus measure -- the Zacks Consensus Estimate.Since a changing earnings picture is a powerful factor influencing near-term stock price movements, the Zacks rating system is very useful for individual investors. They may find it difficult to make decisions based on rating upgrades by Wall Street analysts, as these are mostly driven by subjective factors that are hard to see and measure in real time.Therefore, the Zacks rating upgrade for Allogene Therapeutics basically reflects positivity about its earnings outlook that could translate into buying pres","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/allogene-therapeutics-allo-upgraded-buy-170010826.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ALLO"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":81,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-13","symbol":"ALLO","fiscalQuarterEnding":"2025/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-03-13","symbol":"ALLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2024-11-07","symbol":"ALLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-08-07","symbol":"ALLO","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.32},{"market":"US","date":"2024-05-13","symbol":"ALLO","fiscalQuarterEnding":"2024/03","expectedEps":-0.38,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715572800000,"reportTimeType":"post","actualEps":-0.38}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3571,"buy":0.5,"hold":0.1429,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":14,"updateTime":1747281600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALLO","date":"2025-06-06","current":-1.11826,"percent":0.9792,"low":-29.693436,"twenty":-15.57827,"median":-3.653074,"eighty":-1.742864,"high":-0.825952,"avg":-7.615796,"sd":7.659069,"marketCap":282162743},"quantilePoints":[{"date":"2020-06-12","current":-26.741264,"twenty":-125167.645342,"median":-21.34254,"eighty":-15.052628,"marketCap":5548491395},{"date":"2020-06-19","current":-26.351604,"twenty":-123317.452191,"median":-21.370232,"eighty":-15.067209,"marketCap":5467641557},{"date":"2020-06-26","current":-28.372554,"twenty":-122766.755092,"median":-21.425301,"eighty":-15.085062,"marketCap":5886964444},{"date":"2020-07-02","current":-29.693436,"twenty":-122411.666725,"median":-21.484956,"eighty":-15.099106,"marketCap":6161031690},{"date":"2020-07-10","current":-28.628112,"twenty":-122130.57855,"median":-21.512647,"eighty":-15.112891,"marketCap":5939989714},{"date":"2020-07-17","current":-28.41417,"twenty":-120852.809358,"median":-21.632371,"eighty":-15.149784,"marketCap":5895599320},{"date":"2020-07-24","current":-25.786695,"twenty":-118796.77005,"median":-21.690696,"eighty":-15.211389,"marketCap":5350429782},{"date":"2020-07-31","current":-24.516415,"twenty":-117386.342967,"median":-21.749941,"eighty":-15.262228,"marketCap":5086861813},{"date":"2020-08-07","current":-23.068229,"twenty":-116963.771775,"median":-21.815069,"eighty":-15.302048,"marketCap":5241539822},{"date":"2020-08-14","current":-22.639109,"twenty":-115764.848892,"median":-21.850929,"eighty":-15.323938,"marketCap":5144035759},{"date":"2020-08-21","current":-22.326465,"twenty":-113858.364958,"median":-21.88451,"eighty":-15.339533,"marketCap":5072997085},{"date":"2020-08-28","current":-21.449836,"twenty":-113052.531558,"median":-21.850929,"eighty":-15.350911,"marketCap":4873810214},{"date":"2020-09-04","current":-20.248302,"twenty":-113013.222625,"median":-21.815069,"eighty":-15.356579,"marketCap":4600798839},{"date":"2020-09-11","current":-19.849834,"twenty":-112698.751042,"median":-21.773611,"eighty":-15.368663,"marketCap":4510259352},{"date":"2020-09-18","current":-23.295049,"twenty":-111676.7184,"median":-21.798486,"eighty":-15.39431,"marketCap":5293077684},{"date":"2020-09-25","current":-22.694282,"twenty":-110733.303667,"median":-21.781903,"eighty":-15.424201,"marketCap":5156571996},{"date":"2020-10-02","current":-22.42455,"twenty":-66346.905025,"median":-21.833475,"eighty":-15.446635,"marketCap":5095283728},{"date":"2020-10-09","current":-25.465166,"twenty":-32.123278,"median":-21.864819,"eighty":-15.456704,"marketCap":5786169657},{"date":"2020-10-16","current":-24.049073,"twenty":-31.053945,"median":-21.899539,"eighty":-15.474746,"marketCap":5464406251},{"date":"2020-10-23","current":-22.252902,"twenty":-30.499998,"median":-21.914568,"eighty":-15.494275,"marketCap":5056282103},{"date":"2020-10-30","current":-20.793896,"twenty":-30.117541,"median":-21.899539,"eighty":-15.519547,"marketCap":4724768290},{"date":"2020-11-06","current":-16.069607,"twenty":-29.763062,"median":-21.864819,"eighty":-15.5887,"marketCap":3899788225},{"date":"2020-11-13","current":-18.537852,"twenty":-29.652871,"median":-21.833475,"eighty":-15.667503,"marketCap":4498784474},{"date":"2020-11-20","current":-18.052296,"twenty":-29.579943,"median":-21.805392,"eighty":-15.676049,"marketCap":4380949146},{"date":"2020-11-27","current":-18.219928,"twenty":-29.522101,"median":-21.773611,"eighty":-15.706189,"marketCap":4421630391},{"date":"2020-12-04","current":-19.451161,"twenty":-29.361862,"median":-21.722315,"eighty":-15.79419,"marketCap":4720427114},{"date":"2020-12-11","current":-15.84995,"twenty":-29.3261,"median":-21.682404,"eighty":-15.838198,"marketCap":3846481767},{"date":"2020-12-18","current":-15.688098,"twenty":-29.203647,"median":-21.66746,"eighty":-15.734976,"marketCap":3807203325},{"date":"2020-12-24","current":-15.797926,"twenty":-29.199397,"median":-21.632371,"eighty":-15.783758,"marketCap":3833856554},{"date":"2020-12-31","current":-14.589816,"twenty":-29.129678,"median":-21.578578,"eighty":-15.683214,"marketCap":3540671036},{"date":"2021-01-08","current":-16.11007,"twenty":-29.094985,"median":-21.512647,"eighty":-15.665105,"marketCap":3909607836},{"date":"2021-01-15","current":-18.722826,"twenty":-29.085837,"median":-21.484956,"eighty":-15.668424,"marketCap":4543674123},{"date":"2021-01-22","current":-17.780615,"twenty":-29.081387,"median":-21.441682,"eighty":-15.679632,"marketCap":4315017475},{"date":"2021-01-29","current":-20.058106,"twenty":-29.079226,"median":-21.417075,"eighty":-15.687578,"marketCap":4867721274},{"date":"2021-02-05","current":-20.358689,"twenty":-29.059413,"median":-21.366276,"eighty":-15.695035,"marketCap":4940666953},{"date":"2021-02-12","current":-20.075448,"twenty":-28.895623,"median":-21.330672,"eighty":-15.713532,"marketCap":4871929678},{"date":"2021-02-19","current":-20.069667,"twenty":-28.779198,"median":-21.3211,"eighty":-15.747172,"marketCap":4870526877},{"date":"2021-02-26","current":-19.510296,"twenty":-28.705134,"median":-21.268993,"eighty":-15.789425,"marketCap":4881885762},{"date":"2021-03-05","current":-19.111209,"twenty":-28.62932,"median":-21.180345,"eighty":-15.813122,"marketCap":4782025812},{"date":"2021-03-12","current":-21.629392,"twenty":-28.549665,"median":-21.223136,"eighty":-15.840479,"marketCap":5412128036},{"date":"2021-03-19","current":-20.803113,"twenty":-28.424864,"median":-21.180345,"eighty":-15.848374,"marketCap":5205375744},{"date":"2021-03-26","current":-18.987548,"twenty":-28.40809,"median":-21.126559,"eighty":-15.84995,"marketCap":4751083292},{"date":"2021-04-01","current":-19.633957,"twenty":-28.393688,"median":-21.081445,"eighty":-15.853418,"marketCap":4912828282},{"date":"2021-04-09","current":-18.447938,"twenty":-28.354062,"median":-21.006281,"eighty":-15.878853,"marketCap":4616061386},{"date":"2021-04-16","current":-18.273688,"twenty":-28.264241,"median":-20.976017,"eighty":-15.933588,"marketCap":4572460563},{"date":"2021-04-23","current":-19.462576,"twenty":-28.191593,"median":-20.927873,"eighty":-15.982492,"marketCap":4869945125},{"date":"2021-04-30","current":-17.483522,"twenty":-28.153287,"median":-20.900528,"eighty":-16.044634,"marketCap":4374744429},{"date":"2021-05-07","current":-18.574304,"twenty":-28.140827,"median":-20.824306,"eighty":-16.056451,"marketCap":4248983398},{"date":"2021-05-14","current":-17.015102,"twenty":-28.110712,"median":-20.785365,"eighty":-16.066082,"marketCap":3892306577},{"date":"2021-05-21","current":-16.09938,"twenty":-28.045215,"median":-20.757114,"eighty":-16.075562,"marketCap":3682829714},{"date":"2021-05-28","current":-15.901386,"twenty":-27.798929,"median":-20.702003,"eighty":-15.982492,"marketCap":3637537419},{"date":"2021-06-04","current":-14.731984,"twenty":-27.771552,"median":-20.677935,"eighty":-15.867292,"marketCap":3370029804},{"date":"2021-06-11","current":-16.148878,"twenty":-27.752287,"median":-20.584126,"eighty":-15.84995,"marketCap":3694152788},{"date":"2021-06-18","current":-15.146534,"twenty":-27.745135,"median":-20.567167,"eighty":-15.783758,"marketCap":3464860546},{"date":"2021-06-25","current":-14.960915,"twenty":-27.705487,"median":-20.54455,"eighty":-15.697205,"marketCap":3422399019},{"date":"2021-07-02","current":-16.26025,"twenty":-27.672486,"median":-20.524004,"eighty":-15.697205,"marketCap":3719629703},{"date":"2021-07-09","current":-14.911416,"twenty":-27.651352,"median":-20.43363,"eighty":-15.668424,"marketCap":3411075946},{"date":"2021-07-16","current":-14.001882,"twenty":-27.614367,"median":-20.349588,"eighty":-15.61339,"marketCap":3203014467},{"date":"2021-07-23","current":-13.643018,"twenty":-27.477084,"median":-20.242529,"eighty":-15.573595,"marketCap":3120922183},{"date":"2021-07-30","current":-13.581145,"twenty":-27.372009,"median":-20.19926,"eighty":-15.486486,"marketCap":3106768340},{"date":"2021-08-06","current":-13.937332,"twenty":-27.187994,"median":-20.183031,"eighty":-15.440342,"marketCap":3327091981},{"date":"2021-08-13","current":-12.769931,"twenty":-27.13327,"median":-20.135965,"eighty":-15.396829,"marketCap":3048412481},{"date":"2021-08-20","current":-13.967112,"twenty":-27.128016,"median":-20.084647,"eighty":-15.357651,"marketCap":3334201152},{"date":"2021-08-27","current":-14.532944,"twenty":-27.087978,"median":-20.058106,"eighty":-15.319398,"marketCap":3469275399},{"date":"2021-09-03","current":-15.17025,"twenty":-27.066547,"median":-19.991439,"eighty":-15.277942,"marketCap":3621411656},{"date":"2021-09-10","current":-14.735453,"twenty":-26.951342,"median":-19.940072,"eighty":-15.211389,"marketCap":3517617761},{"date":"2021-09-17","current":-15.116645,"twenty":-26.795343,"median":-19.884693,"eighty":-15.124129,"marketCap":3608615148},{"date":"2021-09-24","current":-15.283416,"twenty":-26.678135,"median":-19.849922,"eighty":-15.11715,"marketCap":3648426505},{"date":"2021-10-01","current":-14.604418,"twenty":-26.569222,"median":-19.821108,"eighty":-15.112387,"marketCap":3486337409},{"date":"2021-10-08","current":-7.820392,"twenty":-26.52467,"median":-19.746249,"eighty":-15.06736,"marketCap":1866868278},{"date":"2021-10-15","current":-9.815694,"twenty":-26.488509,"median":-19.739643,"eighty":-15.039637,"marketCap":2343182728},{"date":"2021-10-22","current":-9.422589,"twenty":-26.410782,"median":-19.66854,"eighty":-14.968339,"marketCap":2249341672},{"date":"2021-10-29","current":-10.268359,"twenty":-26.360977,"median":-19.633957,"eighty":-14.938394,"marketCap":2451242126},{"date":"2021-11-05","current":-11.448707,"twenty":-26.35097,"median":-19.577031,"eighty":-14.909523,"marketCap":2870270991},{"date":"2021-11-12","current":-10.948466,"twenty":-26.268966,"median":-19.520526,"eighty":-14.896677,"marketCap":2744856965},{"date":"2021-11-19","current":-10.69266,"twenty":-25.997664,"median":-19.458331,"eighty":-14.830197,"marketCap":2680724793},{"date":"2021-11-26","current":-10.220842,"twenty":-25.82651,"median":-19.416087,"eighty":-14.809383,"marketCap":2562436565},{"date":"2021-12-03","current":-10.016198,"twenty":-25.773439,"median":-19.283528,"eighty":-14.742014,"marketCap":2511130827},{"date":"2021-12-10","current":-10.249265,"twenty":-25.711764,"median":-19.163016,"eighty":-14.695169,"marketCap":2569562362},{"date":"2021-12-17","current":-8.987292,"twenty":-25.583781,"median":-19.115579,"eighty":-14.620796,"marketCap":2253176979},{"date":"2021-12-23","current":-8.902023,"twenty":-25.481704,"median":-19.099967,"eighty":-14.591026,"marketCap":2231799589},{"date":"2021-12-31","current":-8.481366,"twenty":-25.460584,"median":-19.052311,"eighty":-14.49675,"marketCap":2126337794},{"date":"2022-01-07","current":-7.65142,"twenty":-25.434926,"median":-18.972964,"eighty":-14.45075,"marketCap":1918264525},{"date":"2022-01-14","current":-7.549098,"twenty":-25.370845,"median":-18.912042,"eighty":-14.374511,"marketCap":1892611656},{"date":"2022-01-21","current":-6.457662,"twenty":-25.231783,"median":-18.839368,"eighty":-14.322288,"marketCap":1618981055},{"date":"2022-01-28","current":-6.037004,"twenty":-25.124812,"median":-18.790783,"eighty":-14.276831,"marketCap":1513519261},{"date":"2022-02-04","current":-6.264387,"twenty":-25.073649,"median":-18.741054,"eighty":-14.246482,"marketCap":1570525636},{"date":"2022-02-11","current":-5.76983,"twenty":-24.932692,"median":-18.689285,"eighty":-14.211106,"marketCap":1446536770},{"date":"2022-02-18","current":-5.286642,"twenty":-24.919572,"median":-18.675482,"eighty":-14.155515,"marketCap":1325398223},{"date":"2022-02-25","current":-5.237841,"twenty":-24.910169,"median":-18.641491,"eighty":-14.089501,"marketCap":1346151378},{"date":"2022-03-04","current":-4.465773,"twenty":-24.856433,"median":-18.614852,"eighty":-13.975129,"marketCap":1147726096},{"date":"2022-03-11","current":-4.537981,"twenty":-24.80629,"median":-18.575761,"eighty":-13.919313,"marketCap":1166283856},{"date":"2022-03-18","current":-5.421138,"twenty":-24.791816,"median":-18.537852,"eighty":-13.824271,"marketCap":1393259539},{"date":"2022-03-25","current":-5.360039,"twenty":-24.745062,"median":-18.517177,"eighty":-13.759752,"marketCap":1377556819},{"date":"2022-04-01","current":-5.24895,"twenty":-24.663369,"median":-18.481663,"eighty":-13.698958,"marketCap":1349006418},{"date":"2022-04-08","current":-4.910129,"twenty":-24.556916,"median":-18.469454,"eighty":-13.641781,"marketCap":1261927697},{"date":"2022-04-14","current":-4.608672,"twenty":-24.523728,"median":-18.439507,"eighty":-13.603773,"marketCap":1184451691},{"date":"2022-04-22","current":-4.35729,"twenty":-24.477635,"median":-18.313035,"eighty":-13.564932,"marketCap":1119845235},{"date":"2022-04-29","current":-4.665479,"twenty":-24.441832,"median":-18.271722,"eighty":-13.51369,"marketCap":1199051399},{"date":"2022-05-06","current":-4.338635,"twenty":-24.350625,"median":-18.24883,"eighty":-13.47653,"marketCap":1318250882},{"date":"2022-05-13","current":-3.41703,"twenty":-24.272198,"median":-18.214147,"eighty":-13.43938,"marketCap":1038230270},{"date":"2022-05-20","current":-3.535184,"twenty":-24.194972,"median":-18.163547,"eighty":-13.367297,"marketCap":1074130348},{"date":"2022-05-27","current":-3.780946,"twenty":-24.101793,"median":-18.077113,"eighty":-13.243821,"marketCap":1148802512},{"date":"2022-06-03","current":-3.932183,"twenty":-24.060108,"median":-18.06159,"eighty":-13.190251,"marketCap":1194754612},{"date":"2022-06-10","current":-4.603301,"twenty":-24.027743,"median":-17.98293,"eighty":-13.117204,"marketCap":1398667058},{"date":"2022-06-17","current":-5.179895,"twenty":-23.989114,"median":-17.951138,"eighty":-12.938707,"marketCap":1573859441},{"date":"2022-06-24","current":-5.803751,"twenty":-23.979164,"median":-17.921762,"eighty":-12.772357,"marketCap":1763411855},{"date":"2022-07-01","current":-5.439835,"twenty":-23.96372,"median":-17.857317,"eighty":-12.530495,"marketCap":1652839614},{"date":"2022-07-08","current":-5.685597,"twenty":-23.901946,"median":-17.780615,"eighty":-12.328703,"marketCap":1727511777},{"date":"2022-07-15","current":-6.054239,"twenty":-23.879665,"median":-17.691917,"eighty":-11.170164,"marketCap":1839520022},{"date":"2022-07-22","current":-6.314179,"twenty":-23.828383,"median":-17.626932,"eighty":-10.948466,"marketCap":1918500195},{"date":"2022-07-29","current":-6.134584,"twenty":-23.705543,"median":-17.59185,"eighty":-10.800667,"marketCap":1863932075},{"date":"2022-08-05","current":-7.306677,"twenty":-23.697251,"median":-17.538967,"eighty":-10.69266,"marketCap":2220060854},{"date":"2022-08-12","current":-8.062204,"twenty":-23.570911,"median":-17.452841,"eighty":-10.510754,"marketCap":2480667731},{"date":"2022-08-19","current":-6.921811,"twenty":-23.514837,"median":-17.370093,"eighty":-10.266318,"marketCap":2129779078},{"date":"2022-08-26","current":-6.59465,"twenty":-23.443168,"median":-17.343792,"eighty":-10.220842,"marketCap":2029114300},{"date":"2022-09-02","current":-6.636713,"twenty":-23.37196,"median":-17.295567,"eighty":-9.815694,"marketCap":2042056915},{"date":"2022-09-09","current":-7.043329,"twenty":-23.333983,"median":-17.225694,"eighty":-9.494063,"marketCap":2167168852},{"date":"2022-09-16","current":-6.389005,"twenty":-23.304303,"median":-17.168273,"eighty":-9.413059,"marketCap":1965839297},{"date":"2022-09-23","current":-4.963514,"twenty":-23.295891,"median":-17.123016,"eighty":-8.970238,"marketCap":1527228481},{"date":"2022-09-30","current":-5.047641,"twenty":-23.22545,"median":-17.01924,"eighty":-8.791743,"marketCap":1553113710},{"date":"2022-10-07","current":-4.841996,"twenty":-23.18815,"median":-16.933399,"eighty":-8.734897,"marketCap":1489838707},{"date":"2022-10-14","current":-4.757869,"twenty":-23.163275,"median":-16.832624,"eighty":-8.377907,"marketCap":1463953478},{"date":"2022-10-21","current":-4.701784,"twenty":-23.131767,"median":-16.626752,"eighty":-8.053946,"marketCap":1446696659},{"date":"2022-10-28","current":-5.03362,"twenty":-23.123748,"median":-16.609019,"eighty":-7.819568,"marketCap":1548799505},{"date":"2022-11-04","current":-4.308044,"twenty":-23.118497,"median":-16.462729,"eighty":-7.719634,"marketCap":1346922838},{"date":"2022-11-11","current":-4.621692,"twenty":-23.078037,"median":-16.372736,"eighty":-7.512226,"marketCap":1444985743},{"date":"2022-11-18","current":-4.723166,"twenty":-23.040787,"median":-16.295044,"eighty":-7.268603,"marketCap":1476711976},{"date":"2022-11-25","current":-4.967627,"twenty":-23.028761,"median":-16.231769,"eighty":-7.107827,"marketCap":1553143358},{"date":"2022-12-02","current":-4.363393,"twenty":-22.975759,"median":-16.162506,"eighty":-6.958297,"marketCap":1364228056},{"date":"2022-12-09","current":-4.040521,"twenty":-22.92282,"median":-16.136504,"eighty":-6.795851,"marketCap":1263280949},{"date":"2022-12-16","current":-3.187214,"twenty":-22.884679,"median":-16.118741,"eighty":-6.737666,"marketCap":996492164},{"date":"2022-12-23","current":-2.74903,"twenty":-22.855762,"median":-16.09938,"eighty":-6.648267,"marketCap":859492517},{"date":"2022-12-30","current":-2.901242,"twenty":-22.845812,"median":-16.065201,"eighty":-6.624678,"marketCap":907081868},{"date":"2023-01-06","current":-2.808992,"twenty":-22.842858,"median":-16.042226,"eighty":-6.551135,"marketCap":878239837},{"date":"2023-01-13","current":-3.256401,"twenty":-22.839916,"median":-15.931803,"eighty":-6.459821,"marketCap":1018123687},{"date":"2023-01-20","current":-3.021166,"twenty":-22.833946,"median":-15.884339,"eighty":-6.44509,"marketCap":944576508},{"date":"2023-01-27","current":-3.653074,"twenty":-22.804627,"median":-15.84995,"eighty":-6.403977,"marketCap":1142144419},{"date":"2023-02-03","current":-3.588499,"twenty":-22.792366,"median":-15.822247,"eighty":-6.365636,"marketCap":1121954998},{"date":"2023-02-10","current":-3.168765,"twenty":-22.752014,"median":-15.783758,"eighty":-6.281441,"marketCap":990723757},{"date":"2023-02-17","current":-3.320976,"twenty":-22.724933,"median":-15.698432,"eighty":-6.150644,"marketCap":1038313108},{"date":"2023-02-24","current":-2.855117,"twenty":-22.720065,"median":-15.692652,"eighty":-6.050792,"marketCap":892660853},{"date":"2023-03-03","current":-2.602093,"twenty":-22.718848,"median":-15.668884,"eighty":-5.957523,"marketCap":865539324},{"date":"2023-03-10","current":-2.476115,"twenty":-22.699195,"median":-15.650358,"eighty":-5.791024,"marketCap":823635083},{"date":"2023-03-17","current":-2.38489,"twenty":-22.694036,"median":-15.59202,"eighty":-5.754599,"marketCap":793290632},{"date":"2023-03-24","current":-2.180719,"twenty":-22.650082,"median":-15.578958,"eighty":-5.643062,"marketCap":725376862},{"date":"2023-03-31","current":-2.145966,"twenty":-22.606719,"median":-15.536778,"eighty":-5.533933,"marketCap":713817072},{"date":"2023-04-06","current":-2.145966,"twenty":-22.596133,"median":-15.486836,"eighty":-5.526161,"marketCap":713817072},{"date":"2023-04-14","current":-2.193751,"twenty":-22.59183,"median":-15.476469,"eighty":-5.47859,"marketCap":729711784},{"date":"2023-04-21","current":-2.167687,"twenty":-22.582762,"median":-15.444878,"eighty":-5.423849,"marketCap":721041941},{"date":"2023-04-28","current":-2.331585,"twenty":-22.567942,"median":-15.411502,"eighty":-5.378822,"marketCap":775559814},{"date":"2023-05-05","current":-2.67629,"twenty":-22.556495,"median":-15.387839,"eighty":-5.296718,"marketCap":940678449},{"date":"2023-05-12","current":-2.564259,"twenty":-22.5382,"median":-15.360906,"eighty":-5.264421,"marketCap":901301211},{"date":"2023-05-19","current":-2.522766,"twenty":-22.523168,"median":-15.347235,"eighty":-5.220067,"marketCap":886717049},{"date":"2023-05-26","current":-2.26966,"twenty":-22.494685,"median":-15.329523,"eighty":-5.146724,"marketCap":797753661},{"date":"2023-06-02","current":-2.207421,"twenty":-22.461519,"median":-15.318827,"eighty":-5.12616,"marketCap":775877418},{"date":"2023-06-09","current":-2.406586,"twenty":-22.436936,"median":-15.307241,"eighty":-5.087067,"marketCap":845881396},{"date":"2023-06-16","current":-2.062196,"twenty":-22.431982,"median":-15.280863,"eighty":-5.062594,"marketCap":724832851},{"date":"2023-06-23","current":-1.950165,"twenty":-22.42371,"median":-15.264093,"eighty":-5.040163,"marketCap":685455614},{"date":"2023-06-30","current":-1.900373,"twenty":-22.420352,"median":-15.20471,"eighty":-4.999,"marketCap":667954619},{"date":"2023-07-07","current":-2.082942,"twenty":-22.399189,"median":-15.158392,"eighty":-4.959528,"marketCap":732124932},{"date":"2023-07-14","current":-2.163853,"twenty":-22.385151,"median":-15.117486,"eighty":-4.907907,"marketCap":760564048},{"date":"2023-07-21","current":-2.190823,"twenty":-22.379709,"median":-15.097383,"eighty":-4.870137,"marketCap":770043753},{"date":"2023-07-28","current":-1.962613,"twenty":-22.365629,"median":-15.070241,"eighty":-4.834519,"marketCap":689830862},{"date":"2023-08-04","current":-2.429176,"twenty":-22.333634,"median":-15.048949,"eighty":-4.780355,"marketCap":861599516},{"date":"2023-08-11","current":-1.989656,"twenty":-22.302039,"median":-15.039215,"eighty":-4.750531,"marketCap":705706996},{"date":"2023-08-18","current":-1.890409,"twenty":-22.281125,"median":-14.976471,"eighty":-4.726099,"marketCap":670505460},{"date":"2023-08-25","current":-1.800615,"twenty":-22.26271,"median":-14.959059,"eighty":-4.690269,"marketCap":638656450},{"date":"2023-09-01","current":-1.838423,"twenty":-22.254128,"median":-14.935942,"eighty":-4.655464,"marketCap":652066559},{"date":"2023-09-08","current":-1.890409,"twenty":-22.226501,"median":-14.915859,"eighty":-4.613716,"marketCap":670505460},{"date":"2023-09-15","current":-1.866779,"twenty":-22.199407,"median":-14.907739,"eighty":-4.562564,"marketCap":662124141},{"date":"2023-09-22","current":-1.758081,"twenty":-22.155099,"median":-14.902096,"eighty":-4.535759,"marketCap":623570077},{"date":"2023-09-29","current":-1.611574,"twenty":-22.125027,"median":-14.890312,"eighty":-4.47888,"marketCap":571605904},{"date":"2023-10-06","current":-1.488697,"twenty":-22.083887,"median":-14.828304,"eighty":-4.453624,"marketCap":528023049},{"date":"2023-10-13","current":-1.398903,"twenty":-22.021504,"median":-14.806926,"eighty":-4.392913,"marketCap":496174040},{"date":"2023-10-20","current":-1.408355,"twenty":-21.920407,"median":-14.732656,"eighty":-4.341249,"marketCap":499526567},{"date":"2023-10-27","current":-1.24767,"twenty":-21.858588,"median":-14.678091,"eighty":-4.324649,"marketCap":442533603},{"date":"2023-11-03","current":-1.500595,"twenty":-21.791299,"median":-14.597163,"eighty":-4.250351,"marketCap":499480406},{"date":"2023-11-10","current":-1.271472,"twenty":-21.701761,"median":-14.505855,"eighty":-4.13646,"marketCap":423215804},{"date":"2023-11-17","current":-1.420611,"twenty":-21.666847,"median":-14.444042,"eighty":-3.884921,"marketCap":472857420},{"date":"2023-11-24","current":-1.435778,"twenty":-21.606973,"median":-14.367423,"eighty":-3.736519,"marketCap":477905720},{"date":"2023-12-01","current":-1.188055,"twenty":-21.531996,"median":-14.285577,"eighty":-3.670601,"marketCap":395450155},{"date":"2023-12-08","current":-1.274,"twenty":-21.460314,"median":-14.255927,"eighty":-3.607628,"marketCap":424057188},{"date":"2023-12-15","current":-1.370055,"twenty":-21.374979,"median":-14.211106,"eighty":-3.560824,"marketCap":456029754},{"date":"2023-12-22","current":-1.395333,"twenty":-21.322326,"median":-14.13984,"eighty":-3.533294,"marketCap":464443587},{"date":"2023-12-29","current":-1.653166,"twenty":-21.268379,"median":-14.008069,"eighty":-3.467127,"marketCap":550264684},{"date":"2024-01-05","current":-1.713833,"twenty":-21.128686,"median":-13.967112,"eighty":-3.374494,"marketCap":570457884},{"date":"2024-01-12","current":-1.622833,"twenty":-20.999951,"median":-13.847237,"eighty":-3.288105,"marketCap":540168085},{"date":"2024-01-19","current":-1.617777,"twenty":-20.926148,"median":-13.775851,"eighty":-3.237951,"marketCap":538485318},{"date":"2024-01-26","current":-1.617777,"twenty":-20.843295,"median":-13.725947,"eighty":-3.189059,"marketCap":538485318},{"date":"2024-02-02","current":-1.875611,"twenty":-20.757114,"median":-13.643018,"eighty":-3.045151,"marketCap":624306416},{"date":"2024-02-09","current":-2.209277,"twenty":-20.678726,"median":-13.581145,"eighty":-2.954746,"marketCap":735369012},{"date":"2024-02-16","current":-2.507555,"twenty":-20.569541,"median":-13.523798,"eighty":-2.866187,"marketCap":834652243},{"date":"2024-02-23","current":-2.204222,"twenty":-20.53631,"median":-13.479021,"eighty":-2.792973,"marketCap":733686246},{"date":"2024-03-01","current":-2.482277,"twenty":-20.368481,"median":-13.450518,"eighty":-2.74483,"marketCap":826238410},{"date":"2024-03-08","current":-2.815944,"twenty":-20.232312,"median":-13.366427,"eighty":-2.733115,"marketCap":937301007},{"date":"2024-03-15","current":-2.316309,"twenty":-20.232312,"median":-13.215177,"eighty":-2.663292,"marketCap":758046859},{"date":"2024-03-22","current":-2.263068,"twenty":-20.232312,"median":-13.137784,"eighty":-2.619459,"marketCap":740622924},{"date":"2024-03-28","current":-2.304402,"twenty":-20.232312,"median":-12.979561,"eighty":-2.590948,"marketCap":754150284},{"date":"2024-04-05","current":-2.092563,"twenty":-20.235598,"median":-12.656765,"eighty":-2.565844,"marketCap":684822567},{"date":"2024-04-12","current":-2.061562,"twenty":-20.235598,"median":-12.436968,"eighty":-2.524426,"marketCap":674677048},{"date":"2024-04-19","current":-1.78772,"twenty":-20.235598,"median":-11.170164,"eighty":-2.507555,"marketCap":585058292},{"date":"2024-04-26","current":-1.489357,"twenty":-20.232312,"median":-10.939939,"eighty":-2.476779,"marketCap":487414450},{"date":"2024-05-03","current":-1.549349,"twenty":-20.232312,"median":-10.763718,"eighty":-2.449125,"marketCap":507047607},{"date":"2024-05-10","current":-1.491965,"twenty":-20.232312,"median":-10.570442,"eighty":-2.423446,"marketCap":488268066},{"date":"2024-05-17","current":-2.150009,"twenty":-20.232312,"median":-10.267339,"eighty":-2.404926,"marketCap":628441086},{"date":"2024-05-24","current":-1.814293,"twenty":-20.232312,"median":-10.217798,"eighty":-2.379795,"marketCap":530312411},{"date":"2024-05-31","current":-1.785721,"twenty":-20.232312,"median":-9.802255,"eighty":-2.357966,"marketCap":521961035},{"date":"2024-06-07","current":-1.65715,"twenty":-20.232312,"median":-9.458326,"eighty":-2.340512,"marketCap":484379840},{"date":"2024-06-14","current":-1.678578,"twenty":-20.232312,"median":-9.154314,"eighty":-2.32815,"marketCap":490643372},{"date":"2024-06-21","current":-1.821436,"twenty":-20.235598,"median":-8.799701,"eighty":-2.306469,"marketCap":532400255},{"date":"2024-06-28","current":-1.664292,"twenty":-20.235598,"median":-8.725802,"eighty":-2.268805,"marketCap":486467684},{"date":"2024-07-05","current":-1.514292,"twenty":-20.235598,"median":-8.23693,"eighty":-2.246424,"marketCap":442622957},{"date":"2024-07-12","current":-1.971437,"twenty":-20.235598,"median":-8.016944,"eighty":-2.21653,"marketCap":576244982},{"date":"2024-07-19","current":-2.021437,"twenty":-20.235598,"median":-7.74439,"eighty":-2.210017,"marketCap":590859891},{"date":"2024-07-26","current":-2.142866,"twenty":-20.235598,"median":-7.542986,"eighty":-2.200432,"marketCap":626353242},{"date":"2024-08-02","current":-1.835722,"twenty":-20.235598,"median":-7.197562,"eighty":-2.189973,"marketCap":536575943},{"date":"2024-08-09","current":-1.736216,"twenty":-20.196095,"median":-7.009064,"eighty":-2.17649,"marketCap":485138717},{"date":"2024-08-16","current":-1.713765,"twenty":-20.124888,"median":-6.798736,"eighty":-2.165305,"marketCap":478865371},{"date":"2024-08-23","current":-1.953243,"twenty":-20.048107,"median":-6.720841,"eighty":-2.145966,"marketCap":545781056},{"date":"2024-08-30","current":-1.968211,"twenty":-19.922246,"median":-6.639568,"eighty":-2.132059,"marketCap":549963287},{"date":"2024-09-06","current":-1.803569,"twenty":-19.84994,"median":-6.582722,"eighty":-2.123837,"marketCap":503958753},{"date":"2024-09-13","current":-2.215172,"twenty":-19.747348,"median":-6.457662,"eighty":-2.11573,"marketCap":618970087},{"date":"2024-09-20","current":-2.095433,"twenty":-19.670151,"median":-6.43706,"eighty":-2.11202,"marketCap":585512244},{"date":"2024-09-27","current":-2.177754,"twenty":-19.580759,"median":-6.378078,"eighty":-2.102674,"marketCap":608514511},{"date":"2024-10-04","current":-2.020596,"twenty":-19.45918,"median":-6.281441,"eighty":-2.095433,"marketCap":564601093},{"date":"2024-10-11","current":-1.983178,"twenty":-19.283528,"median":-6.139327,"eighty":-2.083825,"marketCap":554145517},{"date":"2024-10-18","current":-2.125368,"twenty":-19.113831,"median":-6.025635,"eighty":-2.07858,"marketCap":593876705},{"date":"2024-10-25","current":-1.82602,"twenty":-19.019469,"median":-5.792568,"eighty":-2.070244,"marketCap":510232099},{"date":"2024-11-01","current":-2.035564,"twenty":-18.894558,"median":-5.728133,"eighty":-2.063035,"marketCap":568783323},{"date":"2024-11-08","current":-2.27849,"twenty":-18.761339,"median":-5.576662,"eighty":-2.063035,"marketCap":645790040},{"date":"2024-11-15","current":-1.679276,"twenty":-18.685636,"median":-5.526672,"eighty":-2.058046,"marketCap":475955646},{"date":"2024-11-22","current":-1.63489,"twenty":-18.622972,"median":-5.472919,"eighty":-2.050756,"marketCap":463375321},{"date":"2024-11-29","current":-1.834628,"twenty":-18.573596,"median":-5.421138,"eighty":-2.046637,"marketCap":519986785},{"date":"2024-12-06","current":-1.620095,"twenty":-18.506733,"median":-5.360039,"eighty":-2.024094,"marketCap":459181879},{"date":"2024-12-13","current":-1.398164,"twenty":-18.460267,"median":-5.271168,"eighty":-2.012265,"marketCap":396280251},{"date":"2024-12-20","current":-1.383369,"twenty":-18.27539,"median":-5.237841,"eighty":-1.998145,"marketCap":392086810},{"date":"2024-12-27","current":-1.620095,"twenty":-18.240786,"median":-5.150463,"eighty":-1.991967,"marketCap":459181879},{"date":"2025-01-03","current":-1.597902,"twenty":-18.172298,"median":-5.122421,"eighty":-1.985961,"marketCap":452891716},{"date":"2025-01-10","current":-1.520226,"twenty":-18.067166,"median":-5.083674,"eighty":-1.978904,"marketCap":430876147},{"date":"2025-01-17","current":-1.34638,"twenty":-17.952872,"median":-5.049325,"eighty":-1.971016,"marketCap":381603205},{"date":"2025-01-24","current":-1.435153,"twenty":-17.851225,"median":-5.015664,"eighty":-1.964286,"marketCap":406763856},{"date":"2025-01-31","current":-1.331585,"twenty":-17.750154,"median":-4.941866,"eighty":-1.957866,"marketCap":377409763},{"date":"2025-02-07","current":-1.117052,"twenty":-17.69419,"median":-4.886637,"eighty":-1.950502,"marketCap":316604857},{"date":"2025-02-14","current":-1.509129,"twenty":-17.571446,"median":-4.837622,"eighty":-1.930792,"marketCap":427731065},{"date":"2025-02-21","current":-1.6053,"twenty":-17.366922,"median":-4.790586,"eighty":-1.924363,"marketCap":454988437},{"date":"2025-02-28","current":-1.44255,"twenty":-17.20715,"median":-4.750065,"eighty":-1.91409,"marketCap":408860577},{"date":"2025-03-07","current":-1.612697,"twenty":-16.867307,"median":-4.704615,"eighty":-1.893374,"marketCap":457085158},{"date":"2025-03-14","current":-1.636296,"twenty":-16.626752,"median":-4.665479,"eighty":-1.878406,"marketCap":421493591},{"date":"2025-03-21","current":-1.366392,"twenty":-16.626752,"median":-4.608672,"eighty":-1.866779,"marketCap":351968875},{"date":"2025-03-28","current":-1.30735,"twenty":-16.626752,"median":-4.547892,"eighty":-1.852601,"marketCap":336760343},{"date":"2025-04-04","current":-1.214571,"twenty":-16.626752,"median":-4.48793,"eighty":-1.843149,"marketCap":312861222},{"date":"2025-04-11","current":-1.223005,"twenty":-16.62508,"median":-4.455728,"eighty":-1.835722,"marketCap":315033870},{"date":"2025-04-17","current":-1.223005,"twenty":-16.45925,"median":-4.412309,"eighty":-1.830828,"marketCap":315033870},{"date":"2025-04-25","current":-1.30735,"twenty":-16.185215,"median":-4.351703,"eighty":-1.821436,"marketCap":336760343},{"date":"2025-05-02","current":-1.443375,"twenty":-16.121631,"median":-4.308044,"eighty":-1.814293,"marketCap":371798916},{"date":"2025-05-09","current":-0.984891,"twenty":-15.93851,"median":-4.183507,"eighty":-1.800615,"marketCap":253698084},{"date":"2025-05-16","current":-0.962224,"twenty":-15.84995,"median":-4.054358,"eighty":-1.786437,"marketCap":242791197},{"date":"2025-05-23","current":-0.944886,"twenty":-15.697205,"median":-3.786835,"eighty":-1.769444,"marketCap":238416581},{"date":"2025-05-30","current":-1.022905,"twenty":-15.641519,"median":-3.713036,"eighty":-1.758081,"marketCap":258102354},{"date":"2025-06-06","current":-1.11826,"twenty":-15.57827,"median":-3.653074,"eighty":-1.742864,"marketCap":282162743}],"updateTime":1749401273043}}}